Connect with us

Hi, what are you looking for?

Jewish Business News


Gap cuts profit forecast as demand slows for Old Navy brand

A shopper walks down Fifth Avenue carrying a Gap shopping bag in New York
Apparel retailer Gap Inc cut its full-year earnings forecast as sales at the Gap brand continued to fall and demand for the cheaper Old Navy clothing slowed.

The company’s shares fell 4.4 percent in extended trading.

Comparable-store sales fell 5 percent at Gap in the third quarter ended Nov. 1 while sales were flat at Banana Republic.

Comparable sales growth at Old Navy stores slowed to 1 percent from 4 percent in the preceding quarter.

Old Navy brand was Gap’s strong point in North America even when demand for its premium brands cooled.

The company cut its earnings forecast to $2.73-$2.78 per share from $2.95-$3.00 per share for the year ending February 2015.

Apparel sales in North America have been slowing as retailers slash prices to attract shoppers at a time when consumers cut back on discretionary spending.

Gap’s net income rose to $351 million, or 80 cents per share, in the third quarter from $337 million, or 72 cents per share, a year earlier.

The company said net sales fell slightly to $3.97 billion from $3.98 billion from a year earlier.

Analysts on average had expected a profit of 79 cents per share and revenue of $4.04 billion, according to Thomson Reuters I/B/E/S.

The company’s shares closed at $40.14 on the New York Stock Exchange on Wednesday.

1 Comment

1 Comment

  1. samup7775

    December 3, 2014 at 6:10 am

    Old Navy was once a wonderful store that offered up to date clothing styles at agreeable prices. Recently after a visit it was shocking to see it had transformed into a third world country in every aisle, I think I got a bad pair of jeans and ebola in same visit.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...


Now Platika joins and elite club of $10 billion plus Israeli firms.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...